About us

About us
We are a company dedicated to health, with national origin and global vocation.
Faes Farma Websites
All the websites that make up our business lines.
Whistle-blower channel
Internal information System (“Ethics Channel”).

Our purpose

Our mission, vision and values.

Our international presence

National pharmaceutical company with a global vocation.

Our history

We have been taking care of today and tomorrow for more than 90 years.

Our code of ethics

Our ethical principles are an integral part of our corporate culture.

Business

Business
We are engaged in the research, development, manufacture and marketing of prescription medicines, healthcare and animal nutrition products.
Products
A portfolio of premium Active Pharmaceutical Ingredients.

Direct commercialization

We market our own and third-party products.

Out-licensing

We license our own products.

CDMO

We help to develop successful projects.

In-licensing

Launching products from other laboratories.

R&D+i

R&D+i Strategy
Our strategic focus on research for the development and innovation of new medicines.
Therapeutic areas
We generate value for each of our therapeutic areas.

R&D+i News

Our progress in research, development and innovation.

Our clinical trials

We answer all frequently asked questions about clinical trials.

Business

Innovative and quality solutions with an integrated approach to health.

Sustainability

We guarantee integrity, transparency and commitment.

Sustainability

Commitment and SDGs
Our commitment to sustainability and meeting the SDGs.
ESG Strategy
Our strategy and sustainable performance in the past, present and future.
Environment
Our measures to reduce the environmental impact of our activity.
Social
Our commitment to society and to our employees.
Good governance
Our commitment to integrate best practices in good governance.

Sustainability Policy

We manage responsibly, taking into account the concerns of our different stakeholders.

Statement of Non-Financial Information 2023

ESG Strategy

Find out more about our sustainability roadmap.

Whistle-blower channel

Internal information System (“Ethics Channel”).

Investors

Go to Investors
Corporate Governance
Get to know the main governing bodies, the General Shareholders’ Meetings or the internal regulations.
Investor’s corner
Space to consult the agenda, upcoming events and contact with the investor area of the company.

Equity Story

Get to know our business and our vision of the future.

Presentation on business prospects

Results 9M 2024

Annual Report

Talent

News

Resources
Access to the media library.
Press Contacts
Contact our Communications Department.

Dolifen

November 14th, 2023

Diclofenaco dietilamina, principio activo de este medicamento, pertenece al grupo de los antiinflamatorios noesteroideos y actúa como analgésico y antiinflamatorio local.